SEHK:3320Pharmaceuticals
A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation As Board Sets Date For Results And Dividend Decision
China Resources Pharmaceutical Group (SEHK:3320) has scheduled a board meeting for 24 March 2026 to approve its audited 2025 results and consider a final dividend, a key date for investors tracking income and performance.
See our latest analysis for China Resources Pharmaceutical Group.
At a share price of HK$4.55, China Resources Pharmaceutical Group has seen modest short term momentum, with a 1-day share price return of 1.34% and a year to date share price return of 0.89%. However, the...